Notice2024-24878
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 25, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 207 (Friday, October 25, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Pages 85225-85226]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-24878]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Epidemiology and Population Sciences.
Date: November 14-15, 2024.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Address: St. Gregory Hotel, 2033 M Street NW, Washington, DC
20036.
Meeting Format: In Person.
Contact Person: Rebecca I. Tinker, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 435-0637,
<a href="/cdn-cgi/l/email-protection#6f1b0601040a1d1d062f0c1c1d4101060741080019"><span class="__cf_email__" data-cfemail="c3b7aaada8a6b1b1aa83a0b0b1edadaaabeda4acb5">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-24-202: Lasker Clinical Research Scholars Program.
Date: November 15, 2024.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Yue Wu, Ph.D., Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 803C, Bethesda, MD 20892, (301) 867-5309,
<a href="/cdn-cgi/l/email-protection#dbacaea2e9ee9bb8a8a9f5b5b2b3f5bcb4ad"><span class="__cf_email__" data-cfemail="3c4b49450e097c5f4f4e12525554125b534a">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurotechnology and Neuroengineering.
Date: November 15, 2024.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Cibu Paul Thomas, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
[[Page 85226]]
Health, 6701 Rockledge Drive, Room 1011-H, Bethesda, MD 20894, (301)
402-4341, <a href="/cdn-cgi/l/email-protection#295d414644485a4a59694448404507474041074e465f"><span class="__cf_email__" data-cfemail="b4c0dcdbd9d5c7d7c4f4d9d5ddd89adadddc9ad3dbc2">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Study In Cancer Biology Area Review.
Date: November 15, 2024.
Time: 11 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Charles Morrow, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD
20892, 301-408-9850, <a href="/cdn-cgi/l/email-protection#630e0c11110c140010230010114d0d0a0b4d040c15"><span class="__cf_email__" data-cfemail="721f1d00001d051101321101005c1c1b1a5c151d04">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AREA/REAP: Respiratory, Cardiac and Circulatory Sciences.
Date: November 15, 2024.
Time: 1 p.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kirk E. Dineley, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Room 806E, Bethesda, MD 20892, (301) 867-5309,
<a href="/cdn-cgi/l/email-protection#26424f48434a435f4d436645555408484f4e08414950"><span class="__cf_email__" data-cfemail="7b1f12151e171e02101e3b18080955151213551c140d">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: The Cancer Biotherapeutics Development (CBD).
Date: November 18-19, 2024.
Time: 9 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Laurie Ann Shuman Moss, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
<a href="/cdn-cgi/l/email-protection#14787561667d713a677c6179757a797b6767547a7d7c3a737b62"><span class="__cf_email__" data-cfemail="563a3723243f3378253e233b37383b39252516383f3e78313920">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Clinical Data Management and Analysis/Clinical Informatics
and Digital Health Special Emphasis Panel.
Date: November 18-19, 2024.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Amy Kathleen Wernimont, BS, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198, Bethesda, MD 20892, 301-
827-6427, <a href="/cdn-cgi/l/email-protection#f2939f8bdc8597809c9b9f9d9c86b29c9b9adc959d84"><span class="__cf_email__" data-cfemail="a7c6cade89d0c2d5c9cecac8c9d3e7c9cecf89c0c8d1">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Metabolic, Cerebrovascular, Environmental, and
Sleep Factors in Alzheimer's Disease and Related Dementias (ADRD).
Date: November 18-19, 2024.
Time: 9 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jennifer Kielczewski, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
<a href="/cdn-cgi/l/email-protection#83e9e6ededeae5e6f1ade8eae6efe0f9e6f4f0e8eac3edeaebade4ecf5"><span class="__cf_email__" data-cfemail="dbb1beb5b5b2bdbea9f5b0b2beb7b8a1beaca8b0b29bb5b2b3f5bcb4ad">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: The Cancer Drug Development and Therapeutics
(CDDT).
Date: November 18-19, 2024.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lilia Topol, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, <a href="/cdn-cgi/l/email-protection#f19d859e819e9db19c90989ddf9f9899df969e87"><span class="__cf_email__" data-cfemail="660a120916090a260b070f0a48080f0e48010910">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-22-180: Maximizing Investigators' Research Award.
Date: November 18, 2024.
Time: 9:30 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mollie Kim Manier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0510,
<a href="/cdn-cgi/l/email-protection#9ff2f0f3f3f6fab1f2fef1f6faeddff1f6f7b1f8f0e9"><span class="__cf_email__" data-cfemail="7815171414111d56151916111d0a38161110561f170e">[email protected]</span></a>.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; HIV/AIDS Intra- and Inter-personal
Determinants and Behavioral Interventions Study Section.
Date: November 18-19, 2024.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mark P. Rubert, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD
20892, 301-806-6596, <a href="/cdn-cgi/l/email-protection#730106111601071e331000015d1d1a1b5d141c05"><span class="__cf_email__" data-cfemail="c1b3b4a3a4b3b5ac81a2b2b3efafa8a9efa6aeb7">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 21, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-24878 Filed 10-24-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 25, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.